Tag: Ulcerative Colitis
Loss to Follow-Up Common With IBD, But Many Have Flare-Ups
Predictors of follow-up loss are long travel time and low C-reactive protein levels at diagnosis
FDA Approves New Treatment for Ulcerative Colitis
First oral medication approved for chronic use in moderate-to-severe active ulcerative colitis
Predictors of Infliximab Response in Ulcerative Colitis Identified
Baseline Mayo Endoscopic Score, CRP/albumin ratio predict treatment response and risk for colectomy
Clinical Feature Model Predicts Colitis Outcomes
Clinical features can predict both colectomy and steroid dependence
Most Ulcerative Colitis Patients Do Not Achieve Target Remission
Thirty-five percent of patients in real-world care met target of clinical and endoscopic remission
Tofacitinib Found to Relieve Symptoms of Ulcerative Colitis
But treatment isn't yet approved by FDA to treat inflammatory bowel condition
Relapse Rate 18.6 Percent for Ulcerative Colitis
Independent predictors of relapse were NSAID use and vitamin A intake for patients in remission
